TNL MEDIAGENE (TNMG) Fundamental Analysis & Valuation

NASDAQ:TNMG • KYG8924F1211

Current stock price

1.17 USD
-0.01 (-0.85%)
Last:

This TNMG fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

1

1. TNMG Profitability Analysis

1.1 Basic Checks

  • TNMG had negative earnings in the past year.
  • TNMG had a negative operating cash flow in the past year.
  • The reported net income has been mixed in the past 5 years: TNMG reported negative net income in multiple years.
  • In the past 5 years TNMG always reported negative operating cash flow.
TNMG Yearly Net Income VS EBIT VS OCF VS FCFTNMG Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 0 -20M -40M -60M -80M

1.2 Ratios

  • TNMG has a Return On Assets of -98.72%. This is amonst the worse of the industry: TNMG underperforms 84.44% of its industry peers.
  • TNMG has a worse Return On Equity (-243.67%) than 76.67% of its industry peers.
Industry RankSector Rank
ROA -98.72%
ROE -243.67%
ROIC N/A
ROA(3y)-28.56%
ROA(5y)N/A
ROE(3y)-75.91%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
TNMG Yearly ROA, ROE, ROICTNMG Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 0 -50 -100 -150 -200

1.3 Margins

  • Looking at the Gross Margin, with a value of 36.58%, TNMG is in line with its industry, outperforming 47.78% of the companies in the same industry.
  • TNMG does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 36.58%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
TNMG Yearly Profit, Operating, Gross MarginsTNMG Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 0 -50 -100 -150

1

2. TNMG Health Analysis

2.1 Basic Checks

  • TNMG does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • Compared to 1 year ago, TNMG has about the same amount of shares outstanding.
  • Compared to 1 year ago, TNMG has a worse debt to assets ratio.
TNMG Yearly Shares OutstandingTNMG Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2024 5M 10M 15M 20M
TNMG Yearly Total Debt VS Total AssetsTNMG Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2024 50M 100M 150M

2.2 Solvency

  • TNMG has an Altman-Z score of -3.43. This is a bad value and indicates that TNMG is not financially healthy and even has some risk of bankruptcy.
  • TNMG has a worse Altman-Z score (-3.43) than 78.89% of its industry peers.
  • A Debt/Equity ratio of 0.21 indicates that TNMG is not too dependend on debt financing.
  • TNMG has a Debt to Equity ratio (0.21) which is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.21
Debt/FCF N/A
Altman-Z -3.43
ROIC/WACCN/A
WACC5.35%
TNMG Yearly LT Debt VS Equity VS FCFTNMG Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 0 50M 100M 150M

2.3 Liquidity

  • A Current Ratio of 0.38 indicates that TNMG may have some problems paying its short term obligations.
  • TNMG has a worse Current ratio (0.38) than 85.56% of its industry peers.
  • A Quick Ratio of 0.38 indicates that TNMG may have some problems paying its short term obligations.
  • TNMG's Quick ratio of 0.38 is on the low side compared to the rest of the industry. TNMG is outperformed by 85.56% of its industry peers.
Industry RankSector Rank
Current Ratio 0.38
Quick Ratio 0.38
TNMG Yearly Current Assets VS Current LiabilitesTNMG Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2024 10M 20M 30M

3

3. TNMG Growth Analysis

3.1 Past

  • The earnings per share for TNMG have decreased strongly by -10569.97% in the last year.
  • TNMG shows a strong growth in Revenue. In the last year, the Revenue has grown by 35.31%.
EPS 1Y (TTM)-10569.97%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%27.14%
Revenue 1Y (TTM)35.31%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%5.72%

3.2 Future

  • TNMG is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 41.35% yearly.
  • Based on estimates for the next years, TNMG will show a small growth in Revenue. The Revenue will grow by 7.46% on average per year.
EPS Next Y99.69%
EPS Next 2Y41.35%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year3.25%
Revenue Next 2Y7.46%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

TNMG Yearly Revenue VS EstimatesTNMG Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2023 2024 2025 2026 10M 20M 30M 40M 50M
TNMG Yearly EPS VS EstimatesTNMG Yearly EPS VS EstimatesYearly EPS VS Estimates 2025 2026 -0.05 -0.1 -0.15 -0.2

1

4. TNMG Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for TNMG. In the last year negative earnings were reported.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for TNMG. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
TNMG Price Earnings VS Forward Price EarningsTNMG Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
TNMG Per share dataTNMG EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -20 -40 -60

4.3 Compensation for Growth

  • A more expensive valuation may be justified as TNMG's earnings are expected to grow with 41.35% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y41.35%
EPS Next 3YN/A

0

5. TNMG Dividend Analysis

5.1 Amount

  • No dividends for TNMG!.
Industry RankSector Rank
Dividend Yield 0%

TNMG Fundamentals: All Metrics, Ratios and Statistics

TNL MEDIAGENE

NASDAQ:TNMG (4/23/2026, 4:30:35 PM)

1.17

-0.01 (-0.85%)

Chartmill FA Rating
GICS IndustryGroupMedia & Entertainment
GICS IndustryMedia
Earnings (Last)N/A
Earnings (Next)N/A
Inst Owners6.83%
Inst Owner ChangeN/A
Ins Owners16.57%
Ins Owner ChangeN/A
Market Cap3.00M
Revenue(TTM)48.49M
Net Income(TTM)-84.95M
Analysts82.86
Price Target14.28 (1120.51%)
Short Float %4.86%
Short Ratio2.62
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-80%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)95.8%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-15.61%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.06
P/FCF N/A
P/OCF N/A
P/B 0.09
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-70.1
EYN/A
EPS(NY)-0.14
Fwd EYN/A
FCF(TTM)-7.57
FCFYN/A
OCF(TTM)-4.35
OCFYN/A
SpS18.94
BVpS13.62
TBVpS-11.76
PEG (NY)N/A
PEG (5Y)N/A
Graham Number0 (-100%)
Profitability
Industry RankSector Rank
ROA -98.72%
ROE -243.67%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 36.58%
FCFM N/A
ROA(3y)-28.56%
ROA(5y)N/A
ROE(3y)-75.91%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0.56
Health
Industry RankSector Rank
Debt/Equity 0.21
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 253.36%
Cap/Sales 17.02%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.38
Quick Ratio 0.38
Altman-Z -3.43
F-Score3
WACC5.35%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-10569.97%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%27.14%
EPS Next Y99.69%
EPS Next 2Y41.35%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)35.31%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%5.72%
Revenue Next Year3.25%
Revenue Next 2Y7.46%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-566.72%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year92.91%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-2793.63%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-1561.7%
OCF growth 3YN/A
OCF growth 5YN/A

TNL MEDIAGENE / TNMG Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for TNL MEDIAGENE?

ChartMill assigns a fundamental rating of 1 / 10 to TNMG.


What is the valuation status of TNL MEDIAGENE (TNMG) stock?

ChartMill assigns a valuation rating of 1 / 10 to TNL MEDIAGENE (TNMG). This can be considered as Overvalued.


Can you provide the profitability details for TNL MEDIAGENE?

TNL MEDIAGENE (TNMG) has a profitability rating of 1 / 10.


What is the financial health of TNL MEDIAGENE (TNMG) stock?

The financial health rating of TNL MEDIAGENE (TNMG) is 1 / 10.